We're partnered with over 50 patient advocacy groups to help connect patients with support & community.
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Probably Genetic
Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enab
Overview
Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients. In doing so, we help patients access diagnoses, clinical trials, and treatments as early as possible.
Product & workflow
Founders & team
Previously Aiwa Health
Lukas Lange
FounderCEO & Co-Founder of Probably Genetic. Previously BCG & The Bill & Melinda Gates Foundation. PhD from Oxford as a Rhodes Scholar.
Founded 2019 · Source
News & product activity
Sources & observations
Maturity: Not assessed · 3 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-08
- Product visualsNot documented
- Founders & originsTeam information
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2019 Q1 (quarter only)





